JULIE BALL: Open Payments
NPI 1881395499 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 11 payments from 11 companies in 2025. Trend: 2023 $477 · 2024 $904 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $33 |
| Astellas Pharma US Inc | 1 | $29 |
| Stemline Therapeutics Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
Products named: KEYTRUDA, Vyloy, Orserdu, ORGOVYX, ALTUVIIIO, TECVAYLI, NINLARO, Venclexta.
Industry payments across SC — which companies pay providers there.
